CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 62 | -29.5% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 88 | -31.2% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 128 | +172.3% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 47 | -59.1% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 115 | +11.7% | 0.00% | – |
| Q1 2021 | $2,000 | – | 103 | +442.1% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 19 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $159,000 | – | 9,186 | +61140.0% | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 15 | -97.5% | 0.00% | -100.0% |
| Q4 2018 | $8,000 | +14.3% | 610 | +30.6% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | -100.0% | 467 | -68.1% | 0.00% | -50.0% |
| Q2 2018 | $22,998,000 | +69590.9% | 1,463 | -26.4% | 0.00% | -33.3% |
| Q1 2018 | $33,000 | -23.3% | 1,987 | -17.6% | 0.00% | -25.0% |
| Q4 2017 | $43,000 | +152.9% | 2,411 | +172.1% | 0.00% | +100.0% |
| Q3 2017 | $17,000 | +750.0% | 886 | +430.5% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 167 | +21.9% | 0.00% | – |
| Q1 2017 | $2,000 | – | 137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |